Uncategorized
Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too.
Bill Harris, a veteran Los Angeles photojournalist, didn’t think much of it when one morning in 2012 he woke up and found a tiny blood spot on the T-shirt he’d slept in. The next morning, he found blood in the same place on his chest — and went straight to his computer.
“Online, I could find only three things that would cause a man’s nipple to discharge blood: being an avid runner, which I wasn’t; having a subtropical fungus, which I didn’t; and breast cancer,” he said. “That was a pretty big shock.”
Harris, then just a few weeks shy of his 61st birthday, immediately called his doctor, who ordered a mammogram and ultrasound. They confirmed a cancerous growth in his right breast. Ten days later, a biopsy came back positive. The next month Harris got a right mastectomy, followed by the removal of his left breast half a year later.
“I walked into a woman’s imaging center and had to get into a pink paper robe,” he recalled. “All the women in the waiting room were staring at me.”
Like many other Ashkenazi men, Harris never had considered that he might have been born with a harmful mutation of the BRCA gene, which elevates the risk not only of breast cancer, but also of melanoma and prostate, ovarian and pancreatic cancer.
“Hundreds of other mutations in the BRCA gene are just as dangerous, but they’re not specific to Ashkenazim,” said Dr. Robert Sidlow, director of the Male BRCA Genetic Risk Program at New York’s Memorial Sloan Kettering Cancer Center. About 1 in 40 Ashkenazi Jews (those of Eastern European descent) carries the harmful mutation, compared to about 1 in 400 in the general population.
“The vast majority of patients I see are relatives of women who have breast or ovarian cancer and then get tested,” he said. Of BRCA mutation carriers, Sidlow added, “Most men are pretty happy to enroll in some kind of surveillance program once they get over the initial shock.”
Sidlow is on the Men’s Leadership Council at Sharsheret, the national Jewish nonprofit organization that educates the community about cancer risks and supports those with breast cancer and ovarian cancer.
Elana Silber, CEO of Sharsheret (Hebrew for “chain”), says it’s crucial that men with a family history of cancer undergo genetic counseling screening for BRCA and other hereditary cancer mutations.
Genetic testing is possible via a standard blood or saliva sample.
While Sharsheret is primarily considered a women’s organization, it has been using November — nicknamed Movember for its focus on men’s health — for an awareness campaign focused on Jewish men’s cancer risks.
“This is not only a women’s issue,” Silber said. “Family history is so important. When a man shares his family history with his doctor, he may not realize that he should mention that his mother had breast cancer or that his sister had ovarian cancer, as these are not generally ‘men’s diseases.’ They are not aware that these cancers could mean that they themselves are at increased risk for cancer and that they can pass on these mutations to the next generation – their daughters and their sons.”
If someone discovers he (or she) is a carrier of one of the genetic mutations with elevated cancer risks — not just BRCA but also such mutations as ATM, TP53, CHEK2, and PALB2 — there are various precautions they can take for themselves and their children. They can monitor their own health more closely, they can get encourage their children to test to see if they are carriers and, for any future children, take steps to prevent the mutated genes from being passed down.
For example, couples can conceive via in vitro fertilization, or IVF, and then test the embryos before implantation to ensure that only those unaffected by the genetic mutation are implanted.
While most women are aware of the risks of breast cancer, men generally are not — even though the disease strikes 2,500 men in the U.S. every year and kills about 500 of them, according to Sidlow. About 1-2% of men with the BRCA1 mutation and 6-7% of men with the BRCA2 mutation will develop cancer by age 80.
“This is why we recommend periodic mammograms starting at about age 50 for men who carry a BRCA2 mutation,” Sidlow said. “We like to educate these men on how to check their chests once a month and have a clinician do a breast checkup on them once a year.”
Since the BRCA1 and BRCA2 mutations also make prostate cancer more likely, men with either mutation should get PSA (prostate-specific antigen) levels in their blood tested annually beginning at age 40, rather than 50, the age at which screening generally begins, Sidlow said.
Sharsheret has been promoting the importance of learning one’s family history, genetic counseling and screening among both men and women. The 20-year-old organization also runs various peer support networks, offers financial assistance to cancer patients, provides mental health counseling and guidance to patients, caregivers, and their friends, and seeks to educate the broader Jewish community about cancer risks and support.
Peggy Cottrell, a certified genetic counselor at Sharsheret, said men in general are more reluctant to get regular checkups than women.
Ashkenazi Jewish men are at elevated risk not just of breast and prostate cancer but also of pancreatic cancer. Pancreatic cancer is particularly difficult because it’s tough to detect early enough and hard to treat. The five-year survival rate is only 11%. About 2% of BRCA1 carriers and 4% of BRCA2 carriers will develop pancreatic cancer, Sidlow estimated.
“Usually by the time pancreas cancer is clinically detected it has already spread microscopically to the liver,” Sidlow said. “But pancreas cancer is potentially curable if caught when the tumor is extremely small.”
Even among those with elevated risks, certain behaviors can improve one’s odds, such as avoiding obesity, smoking and excessive alcohol consumption.
Harris, the California photojournalist, is still fighting at age 71. While he overcame breast cancer 10 years ago, last year he was diagnosed with ampullary cancer, a rare disease related to his BRCA2 status that was discovered thanks to his participation in a UCLA study. Surgeons have removed his gall bladder, half his pancreas and part of his small intestine, and he has had to endure eight rounds of chemotherapy.
“I’m still working through the aftereffects of the chemo. I have to eat smaller quantities than before and take enzymes to supplement my digestive processes,” Harris said.
Meanwhile, his 37-year-old son discovered that he, too, carries the BRCA2 mutation, and he had a double prophylactic mastectomy and reconstruction at age 30 — just to be on the safe side.
“If there’s any history of breast, ovarian or prostate cancer in your family, get tested genetically so that you’re informed,” Harris advised. “Diagnoses happen way too late for men, and the danger is too big.”
—
The post Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too. appeared first on Jewish Telegraphic Agency.
Uncategorized
2026 Tribeca Film Festival to Screen World Premiere of Israeli Films, Including Noga Erez Documentary
A still from “What Is To Come.” Photo: Tribeca Film Festival
Organizers of the 2026 Tribeca Film Festival announced on Thursday the official lineup for this year’s event in June and it includes the world premiere of three Israeli co-productions.
“What Is to Come” will be screened as part of the festival’s International Narrative Competition. The drama from Israel and the United Kingdom is about a woman named Yehudit who unexpectedly loses her husband and is forced to start over on her own. “In the process, she finds that abrupt and painful detours can lead to bright roads,” according to a synopsis of the film. The feature is directed and written by Ruthy Pribar, and stars Ronit Yudkevitch, Yaakov Zada Danielm and Tovit Adis Semay. “What Is to Come” will make its world premiere on June 8.
Pribar’s debut feature film “Asia” screened at the Tribeca Film Festival in 2020 and won three awards, including the Nora Ephron Prize for Pribar, a best actress award for Shira Haas, and best cinematography for Daniella Nowitz. The film also won nine Ophir Awards in Israel.
“Moishe Badhan (or The Tale of a Wedding Entertainer),” will also make its world premiere at the Tribeca Film Festival this year, in the Viewpoints section. Directed by Gidi Dar and written by Shuli Rand, the co-production from Israel and the US is a comedy-drama about a disgraced Hasidic wedding-comedian who is trying to gather enough funds to marry off his daughter. The cast includes Shuli Rand, Tal Friedman, and American Jewish comedian Elon Gold, who is also an executive producer on the film. The world premiere will take place on June 4.
The 2026 Tribeca Film Festival will also feature the world premiere of the documentary “Noga,” about Israeli alternative pop singer Noga Erez. The movie, which was directed and co-produced by Jono and Benji Bergmann, is a c0-production from Austria, Germany, Israel, and the US. It examines how Erez “must redefine her role as an artist on a global stage” after the Israel-Hamas war breaks out in 2023. The film’s world premiere on June 7 will be followed by an acoustic performance by Erez and her longtime partner in music and life Ori Rousso.
Erez is performing twice at the Coachella Valley Music and Arts Festival this month. She has never performed at the festival before and has made history as the first Israeli singer to take to the stage at the annual event in Indio, California.
The 2026 Tribeca Film Festival will run from June 3-14. The event will feature 118 feature films including 103 world premieres, which is the most in the history of the festival, and 86 short films. The festival this year will represent 143 filmmakers, including 55 first-time directors, spanning 44 countries.
“Tribeca began 25 years ago as an act of healing, a mission to reunite our community through the power of storytelling. Today, that purpose feels more urgent than ever,” said Jane Rosenthal, co-chair and co-founder of the Tribeca Festival. “This year’s incredible feature and short film lineup includes stories from filmmakers who make us think, feel, laugh, cry, and ask why. Tribeca remains dedicated to the artists’ voices and diverse perspectives that challenge us to see one another more clearly.”
Uncategorized
Over 1,000 Entertainment Industry Figures Back Israel’s Inclusion in 2026 Eurovision Song Contest
A photographer takes a picture of a TV screen in Wiener Stadthalle, the venue of next year’s Eurovision in Vienna, Austria, Nov. 18, 2025. Photo: REUTERS/Leonhard Foeger
More than 1,000 members of the entertainment industry have signed an open letter expressing support for Israel’s participation in the 2026 Eurovision Song Contest (ESC) held in May, in response to demands to have the country excluded from the competition because of its military actions in the Gaza Strip during the Israel-Hamas war.
Creative Community for Peace, a non-profit organization comprised of prominent members of the entertainment industry, penned the initial open letter in 2024 in response to efforts by anti-Israel activists to have the European Broadcasting Union, which organizes the ESC, ban Israel from the event and to pressure countries and artists to withdraw their participation from the competition. The open letter voiced support for Israel’s inclusion in Eurovision as well as solidarity with the contest’s participants, while denouncing calls for a boycott of the event.
Hundreds more entertainment industry leaders have since added their names to the open letter, including actresses Amy Schumer and Mila Kunis; singer Matisyahu; actors Jeremy Piven and Jerry O’Connell; television writer, producer, and directors Amy Sherman-Palladino and Matthew Weiner; “Wonder Woman” director Patty Jenkins; and “Nobody Wants This” co-creator Erin Foster.
“We have been shocked and disappointed to see some members of the entertainment community calling for Israel to be banished from the contest for responding to the greatest massacre of Jews since the Holocaust,” the letter stated. “We believe that unifying events such as singing competitions are crucial to help bridge our cultural divides and unite people of all backgrounds through their shared love of music.”
“Music should bring us together,” said O’Connell. “No artist should be silenced for where they are from. These boycott efforts destroy the very connections the arts are meant to build.”
Those who signed the initial open letter back in 2024 include Helen Mirren, Boy George, Liev Schrieber, Sharon Osbourne, Gene Simmons, Debra Messing, David Draiman, Mayim Bialik, Julianna Margulies, and Ginnifer Goodwin.
“Artists and culture are being dragged into the angry, misinformed politics of the moment,” said Osbourne in a released statement. “Attempts to exclude Israelis from the international stage twist art into a tool of division and erode the shared humanity that the arts are meant to preserve. I’ve watched this play out for over three years, and it just breaks my heart.”
The 2026 Eurovision semi-finals will take place on May 12 and 14, and the final live show will be on May 16. The competition is being held in Vienna, Austria.
After the European Broadcasting Union confirmed late last year that it will allow Israel to participate in the 2026 ESC, Spain, the Netherlands, Ireland, Slovenia, and Iceland announced they will not participate in this year’s event.
Spain’s national broadcaster RTVE said it will not broadcast or participate in the event, which marks the first time the country has completely boycotted the ESC since it began participating in the competition in 1961. Spain’s Culture Minister Ernest Urtasun called the move “brave.”
Meanwhile, the EBU confirmed this week that for the first time ever the live shows of the 2026 Eurovision Song Contest will be available to watch for free in the United States. It will air on YouTube but also be available for viewing in the US on the Peacock streaming service.
Uncategorized
Yale University Admits Role in Crumbling Public Trust in Higher Education
Graduates enter Old Campus at Yale University for Commencement Day exercises, in New Haven, Connecticut, US May 19, 2025. Photo: REUTERS/Bryan Woolston
Yale University in New Haven, Connecticut blamed itself and other elite colleges for having played a role in crumbling public trust in higher education in a new committee report published on Wednesday.
Racial preferences in admissions, prohibitive sticker prices, declining academic standards, and advocacy of divisive progressive causes which polarized the American public to the point that “national divorce” became a byword on social media in recent years all contribute to a sense that elite higher education considers itself a class apart and above regular people, the report said.
Citing polling showing that just over a third of Americans, 36 percent, have “confidence” in higher education as opposed to 57 percent who did in 2016, it noted that “trust in higher education has declined faster than in other institutions and sectors.”
The statistics reveal uncertainty regarding the purpose of higher education and its relevance to a democracy that is contemptuous of gatekeepers and hollow indicators of status.
Yale University’s own opaque system of “preferences” in undergraduate admissions — which it said privileges the wealthy, athletes, and some minorities — is one source of discontent that needs to be addressed, the report said.
Yale University infamously adopted racial preferences under the leadership of president Kingman Brewster in the 1960s, despite growing evidence that the practice created an environment of academic maladjustment and racial division. This led to the creation of segregated programming and academic programs for African Americans, as well as a summer remedial program for minority students — PROP (Pre-Orientation Program) — that was eventually rebranded in the late 1990s when its apparent subtext proved unpalatable to a new generation of students.
“We recommend that Yale reduce preferences for special classes of applicants. We also believe that the admissions system can be made more effective and less onerous for applicants by establishing and making a public minimum standard of academic achievement necessary for consideration,” the report continued. “Under the current system, Yale informs potential students that everything matters, leaving applicants scrambling to second-guess what the university wants.”
The report authors, drawn from across Yale’s faculty, went on to recommend adopting a “minimum SAT score” or “Yale specific entrance exam” to “ensure that no student is admitted without the requisite academic preparation ability.”
Elite undergraduate admissions is a matter of growing importance to the Jewish community, as it has seen its representation in some Ivy League institutions plunge. According to a report issued by the Harvard Jewish Alumni Alliance in March, Jewish undergraduate enrollment at Harvard has plummeted to lows not seen since the eve of World War II and the Holocaust, falling to just 7 percent.
The same report also found that Jews are the only minority group at Yale University whose admittance rates have declined since the university expanded the size of its undergraduate class in 2018. The revelation has revived memories of elite education’s 20th century practice of “restriction,” by which admissions officers relied on a “holistic assessment” of applicants to deny admission to Jews.
Yale’s new report also touched on the charged issue of viewpoint diversity, a point of vulnerability for most universities.
“The campus has not been immune from pressures toward conformity, intimidation, and social shaming that have affected the rest of higher education and, indeed, the rest of American society,” it said, referencing a 2015 viral incident in which a Yale undergraduate shrieked at professor Nicholas Christakis because he had implored progressive students not to be hypersensitive over Halloween costumes portraying people of color. “Echo chambers do not produce the best teaching, research, or scholarship.”
Follow Dion J. Pierre @DionJPierre.